ROGNONI, C.; BERTOLANI, A.; JOMMI, C. Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives. Global & Regional Health Technology Assessment, [S. l.], v. 5, n. 1, 2018. DOI: 10.33393/grhta.2018.440. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/440. Acesso em: 1 jul. 2022.